Over 10 years with an implantable cardioverter-defibrillator - A long term follow-up of 60 patients

Kardiologia Polska

Volumn 68, Issue 9, 2010, Pages 1023-1029

  Sterliński, Maciej ^a   Przybylski, Andrzej ^a   Gepner, Katarzyna ^a   Syska, Paweł ^a   Macia̧g, Aleksander ^a   Lewandowski, Michał ^a   Kowalik, Ilona ^a   Pytkowski, Mariusz ^a   Sitkowska Rysiak, Ewa ^a   Lichomski, Jerzy ^a   Szwed, Hanna ^a   Sadowski, Zygmunt ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Appropriate and inappropriate interventions; Complications; Implantable cardioverter defibrillator; Long term observation; Survival

Indexed keywords

ADULT; ARTICLE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; RADIOFREQUENCY ABLATION; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE; T WAVE;

EID: 77958579752     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Trusz-Gluza M, Religa Z, Wnuk-Wojnar A et al. Implantation of an automatic cardioverter-defibrillator - case report. Kardiol Pol, 1989; 32: 404-408.
2. Świa̧tecka G, Lubiński A, Wilczek R et al. Wszczepialny kardiowerter- defibrylator serca z elektroda̧ przezżylna̧. Doświadczenia własne. ESS, 1996; 3: 164-170.
3. Przybylski A, Małecka L, Pytkowski M et al. Implantable cardioverter- defibrillators in patients with hypertrophic cardiomyopathy - dilemmas and difficulties. Kardiol Pol, 2005; 63: 391-397. (Pubitemid 41624884)
4. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). Eur Heart J, 2006; 27: 2099-2140.
5. Moss AJ, Hall WJ, Cannom DS et al.; for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med, 1996; 335: 1933-1940.
6. Moss AJ, Zareba W, Hall WJ et al.; for the MADIT II Investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883. (Pubitemid 34984635)
7. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237. (Pubitemid 40110811)
8. Buxton AE, Lee KL, Fisher JD et al.; for the Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med, 1999; 341: 1882-1890.
9. Desai AS, Fang JC, Maisel WH et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy. A meta-analysis of randomized controlled trials. JAMA, 2004; 292: 2874-2879.
10. Kadish A, Dyer A, Daubert JP et al.; for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med, 2004; 350: 2151-2158.
11. Lee DS, Green LD, Liu PP et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol, 2003; 41: 1573-1582.
12. Cygankiewicz I, Gillespie J, Zareba W et al. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm, 2009; 6: 468-473.
13. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med, 2002; 162: 2405-2410.
14. Goldberg RJ, Gorak EJ, Yarzebski J et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation, 1993; 87: 1947-1953.
15. Yap YG, Duong T, Bland M et al. Temporal trends on the risk of arrhythmic vs.non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J, 2005; 26: 1385-1393.
16. Hauser RG, Hayes DL, Epstein AE et al. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm, 2006; 3: 640-644. (Pubitemid 43758255)
17. Ellenbogen KA, Levine JH, Berger RD et al.; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation, 2006; 113: 776-782.
18. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Eng J Med, 1997; 337: 1576-1583.
19. Connolly SJ, Gent M, Roberts RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter-defibrillator against amiodarone. Circulation, 2000; 101: 1297-1302.
20. Kuck KH, Cappato R, Siebels J et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation, 2000; 102: 748-754.
21. Moss AJ, Greenberg H, Case RB et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation, 2004; 110: 3760-3765.
22. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter-defibrillator recipients: the impact of a device shock. Heart Lung, 2005; 34: 169-178.
23. Duru F, Buchi S, Klaghofer R et al. How different from pacemaker patients are recipients of implantable cardioverter-defibrillator with respect to psychosocial adaptation, affective disorders, and quality of life? Heart, 2001; 85: 375-379.
24. Nanthakumar K, Dorian P, Paquette M et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol, 2003; 8: 215-220.
25. Exner DV, Pinski SL, Wyse DG et al.; AVID Investigators. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation, 2001; 103: 2066-2071.
26. Huang DT, Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter-defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis, 2008; 51: 229-236.
27. Przybylski A, Derejko P, Iwanek M et al. Jedenastoletnia obserwacja pacjenta z przebytym rozległym zawałem serca, niska̧ frakcja̧ wyrzucania oraz nawracaja̧cymi czȩstoskurczami komorowymi. Rola kardiowertera-defibrylatora i wybiórczej ablacji. Kardiol Pol, 2006; 64: 758-762.
28. Kleemann T, Becker T, Doenges K et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of > 10 years. Circulation, 2007; 115: 2474-2480.
29. Ellis CR, Rottman JN. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm, 2009; 6: 619-624.
30. Gepner K, Przybylski A, Macia̧g A et al. Causes of redo procedures in patients with an implantable cardioverter-defibrillator-long-term follow-up results. Kardiol Pol, 2007; 65: 893-898.
31. Lin G, Nishimura RA, Gersh BJ et al. Device complications and inappropriate implantable cardioverter-defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart, 2009; 95: 709-714.
32. Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter- defibrillator replacement in response to device advisories. JAMA, 2006; 295: 1907-1911.
33. Knops P, Theuns DA, Res JC et al. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection. Pacing Clin Electrophysiol, 2009; 32: 1276-1285.
34. Greenberg SM, Epstein AE, Deering T et al. A comparison of ICD implantations in the United States versus Italy. Pacing Clin Electrophysiol, 2007; 30: 1427.